HeraMED

About

Funding history · 4 rounds · $7.4M total

Offices

Q&A

What is HeraMED's primary business?

HeraMED is a medical data and technology company that develops, manufactures, and sells home-based maternity monitoring technology, including HeraBEAT for fetal and maternal heart rate and HeraCARE, a digital maternity and women's health platform.

When was HeraMED founded?

HeraMED was founded in October 2011.

What was HeraMED's most recent funding round?

HeraMED completed a PIPE funding round in January 2026, raising $2,150,000.

When did HeraMED go public and on which exchange?

HeraMED went public on the ASX in December 2018 through an Initial Public Offering, raising $6,000,000.

What was HeraMED's total amount raised in funding?

HeraMED has raised a total of $31,593,500 across all funding rounds.

What is HeraMED's market capitalization?

HeraMED's market capitalization is $25,698,051.

What was HeraMED's financial performance in the first half of 2025?

In the first half of 2025, HeraMED reported an AU$0.003 loss per share, compared to an AU$0.009 loss in 1H 2024.

Team · 13

Anoushka Gungadin

MD, CEO & Director

Cameron Jones

CFO & Company Secretary

Tim Chapman

Chairman

David Hinton

Non Executive Director

Dr Sharon Richardson

NED & Advisory Board Chair

Arturo Weschler

CMO

Moran Shochat

Vp R&d

Nir Pearl

Director Of Operations

Vivek Krishnan

Team Member

Nicole Zappala

Team Member

Dr. Adam Myers

Chairman of the Commercial Scientific Advisory Board

Cheryle Royle

Member of Advisory Board

Paul A. Friedman

Member of Advisory Board

Sectors & technology

Tags